Business Context and Reporting Period
Company: Ginkgo Bioworks Holdings, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: August 19, 2024
Reporting Period: Event date of August 19, 2024
This filing reports the execution of corporate governance amendments effective as of August 19, 2024, specifically regarding the Company's Certificate of Incorporation.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is a current report regarding corporate structural changes and does not contain financial performance data.
Material Changes
On August 19, 2024, the Company filed an Amended and Restated Certificate of Incorporation with the State of Delaware. Material changes include:
- Reverse Stock Split: Implementation of a 1-for-40 reverse stock split for Class A, Class B, and Class C common stock.
- Officer Exculpation: Authorization of Article VIII to permit officer exculpation.
- Charter Cleanup: Removal of provisions related to the merger with Soaring Eagle Acquisition Corp. and the domestication process, as these are no longer relevant.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for future guidance, management outlook, specific risks, or contingencies beyond the structural changes noted above. No unusual items or forward-looking financial statements are included in this report.
Investor Verification Checklist
- Verify the effective date and ratio of the 1-for-40 reverse stock split for all common stock classes.
- Confirm the removal of legacy merger provisions related to Soaring Eagle Acquisition Corp.
- Review the full text of the Amended and Restated Certificate of Incorporation (Exhibit 3.1) for complete legal details.
- Check subsequent trading data to confirm the adjustment of share price and volume post-split.